Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of AST2303 (ABK3376) tablets in adults with locally advanced or met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AST2303 (ABK3376)

Snippet

Sponsor: Allist Pharmaceuticals, Inc. | Conditions: Locally Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 | Status: RECRUITING